Concepedia

Leizhen Zheng

LZ

Statistics

Publications

25

Citations

3.7K

H-Index

20

Active since

2003

Affiliations

XinHua Hospital(Current)

Shanghai Jiao Tong University

Sun Yat-sen University

Nanjing Medical University

Third Affiliated Hospital of Harbin Medical University

Leizhen Zheng is an author at XinHua Hospital specializing in medicine, oncology, and gastrointestinal oncology.

ORCID

Publications per year

2003–2023

25

Publications

25

Randomized, Double-Blind, Placebo-Controlled Phase III Trial of Apatinib in Patients With Chemotherapy-Refractory Advanced or Metastatic Adenocarcinoma of the Stomach or Gastroesophageal Junction

Jin Li, Shukui Qin, Jianming Xu et al. · Journal of Clinical Oncology · 2016 · 997 citations

, , +15

Capecitabine/cisplatin versus 5-fluorouracil/cisplatin as first-line therapy in patients with advanced gastric cancer: a randomised phase III noninferiority trial

Yoon‐Koo Kang, Won Ki Kang, D.B. Shin et al. · Annals of Oncology · 2009 · 777 citations · Full text

, , +15

Stat3 activation regulates the expression of vascular endothelial growth factor and human pancreatic cancer angiogenesis and metastasis

Daoyan Wei, Xiangdong Le, Leizhen Zheng et al. · Oncogene · 2003 · 566 citations

, , +16

Apatinib for Chemotherapy-Refractory Advanced Metastatic Gastric Cancer: Results From a Randomized, Placebo-Controlled, Parallel-Arm, Phase II Trial

Jin Li, Shukui Qin, Jianming Xu et al. · Journal of Clinical Oncology · 2013 · 553 citations · Full text

, , +15

Randomized multicenter phase III study of a modified docetaxel and cisplatin plus fluorouracil regimen compared with cisplatin and fluorouracil as first-line therapy for advanced or locally recurrent gastric cancer

Jinwan Wang, Rui‐Hua Xu, Jian Li et al. · Gastric Cancer · 2015 · 106 citations · Full text

, , +14

1–5 of 25